Introduction
============

Primary liver cancer is the sixth most frequent cancer around the world and the second ordinary cause of cancer-related death. Of them, approximately 70 to 85% of primary liver cancer cases are hepatocellular carcinoma (HCC) [@B1], [@B2]. Due to the high infection of hepatitis B virus (HBV), the high prevalence rate of HCC was observed in East Asia, Southeast Asia and sub-Saharan Africa [@B3]-[@B5]. In 2015, about 500,000 individuals were newly diagnosed, and lead to 420,000 death in China [@B6]-[@B9].

Cytokines are a family of proteins, which are familiarly concerned with both innate and adaptive immune responses to fight against infections. With the background of chronic hepatic inflammation, cytokines comprehensively participate in tumorigenesis process, including IL-6, IL-12, IL-18 and etc. \[10-12\]As a key immunoregulatory cytokine, IL-12 is consisted of two subunits, IL-12-p35 and IL-12-p40, which are translated from IL-12A gene and IL-12B gene, and were link with each other through covalent bond [@B13], [@B14]. IL-12 is an early pro-inflammatory cytokine, mainly secreted by antigen-presenting cells to amplify inflammatory signals. When IL-12 binds to IL-12R complex, the JAK kinase (Tyk-2 and Jak-2) will be activated, thus contributes to the phosphorylation of IL-12R. Study also demonstrated that tyrosine phosphorylation of STAT4 protein, another pivotal molecular of IL-12 signaling pathway, which could regulate gene transcription through DNA homodimerization or translocation in nucleus [@B15]. IL-12 also induces the expression of IFN-γ in T and NK cells through activating JAK/STAT4 pathway and plays a fundamental role in the differentiation of naive T cells to Th1 cells [@B16], [@B17]. As a synergistic manner, IL-18 could together with IL-12 stimulates IFN-γ production by Th1 and NK cells, in addition, IL-12 could also up-regulate IL-18R expression promoting the secreting of IFN-γ [@B18].

As for IL-18, which is a cytokine initially known as an inducer of IFN-γ, plays important roles during both Th1 and Th2 responses [@B19]. These studies demonstrated that genes of IL-12 signaling pathway could functionally work together, contributing to the anti-infection process, and dysregulation of one or more genes in this pathway potentially can influence the whole pathway and thus result in tumorigenesis process. In addition, more evidence has been pointed out that IL-12 signaling pathway plays a pivotal role during anti-HBV-infection, and might contribute to the HCC pathogenesis [@B20], [@B21].

Till now, plenty of studies have examined the associations between polymorphisms in genes of IL-12 signaling pathway and HCC risk, however, these results were controversial and inconsistent. Such as, for *IL12B*-rs3212227 polymorphism, in Yang *et al.*\'s [@B22] work, they suggested that this genetic polymorphism may have an independent effect HCC risk in a Chinese population, on the contrary, another study showed that it has no statistically difference between HCC cases and cancer-free chronic HCV patient groups[@B23]. As for *STAT4*, Chanthra *et al.* [@B24] found out that *STAT4*-rs7574865 polymorphism was related to an increased risk of HCC progression, a results consistent with Clark *et al.*\'s work [@B25]. However, in another study conducted by Chen *et al.*[@B26], they failed to validate the function of rs7574865 polymorphism in STAT4 on the risk of HCC. Due to the heterogeneity within cancer subtypes, the diverse ethnicities of patient cohorts and the small sample sizes, the studies concerned about polymorphisms in genes of IL-12 signaling pathway and HCC risk were not consistent. To overcome these limitations, we exhaustively collected all available genetic polymorphisms in genes of IL-12 signaling pathway and their relevant eligible studies about HCC risk, and performed an updated meta-analysis to comprehensively demonstrate the associations between genetic variations of genes in IL-12 signaling pathway and HCC risk.

Materials and Methods
=====================

Literature filtrating and distinguishing of relevant studies
------------------------------------------------------------

In order to identify all available studies regarding the relationships between genetic polymorphisms in genes of IL-12 signaling pathway and HCC risk, comprehensively literature search was conducted on diverse online databases, including PubMed, Embase, Science Direct and Google Scholar published up to May 30, 2018 by applying below MeSH terms: (\'genes\' OR \'abbreviations of genes\') AND (\'cancer\' OR \'adenocarcinoma\' OR \'tumor\' OR \'carcinoma\' OR \'neoplasms\') AND (\'variant\' OR \'mutation\' OR \'polymorphism\' OR \'SNP\' OR \'genotype\'). Language of eligible studies was restricted to English and Chinese. All of the retrieved articles were reviewed by reading the title and abstract. In addition, full texts of these possibly relevant studies were further read for suitability in current work. Furthermore, in order to identify more eligible studies, the references of each enrolled study were also searched manually.

The Criteria of Inclusion and Exclusion
---------------------------------------

Publications inclusion criteria were demonstrated as: (1) patients were diagnosed by histopathology testing, and control group should be cancer-free, age-matched and sex-matched; (2) case-control studies which focus on the associations between polymorphisms in genes of IL-12 pathway and HCC risk; (3) enrolled articles should have sufficient genotype data, in order to calculate odds ratios (ORs) and 95% confidence intervals (CIs). On the contrast, publications should be excluded when they were: (1) Reviews or conference papers; (2) only case study; or (3) have no sufficient data.

Extracting of Data and Assessing of Article Quality
---------------------------------------------------

Data extraction and quality evaluation of each enrolled publications were conducted by Yao Xiao and Guodong Liu, independently. All the disagreements should be solved after discussion. Furthermore, the following information will be extracted from each publication, including name of the first author, publication year, ethnicity, allele and genotype distribution and Hardy-Weinberg equilibrium (HWE).

Meta-Analysis
-------------

The associations between polymorphisms in gene of IL-12 signaling pathway and HCC risk was assessed by ORs and 95%CI. And the significance of pooled ORs was determined by Z-test. Bonferroni correction was applied to adjust the *P*-value of Z-test, and *P*-adjust less than 1.67\*10^-3^ \[0.05/(five genetic models \* six polymorphisms)\] was considered as statistical significant[@B27]. Five genetic models were used to calculate their associations, including allele (M vs. W), homozygous (MM vs. WW), heterozygous (MW vs. WW), dominant (MW + MM vs. WW), and recessive models (MM vs. WW + WW) (W refers to wild allele and M refers to mutated allele). After that, stratified analyses were also conducted by different cancer type, ethnicity or source of control. Heterogeneity assumption was checked by I^2^ test and Q statistic test. When I^2^ ≤ 50% and *P* ≥ 0.1, the heterogeneity could be ignored, then, the fixed-effect model will be applied; Otherwise, the random-effect model will be selected [@B28]. Moreover, publication bias was appraised with the help of Egger\'s regression test and Begg\'s funnel plot, and the stability of results was confirmed by sensitivity analysis [@B29]. All statistical analyses were conducted by the Stata software (version 12.0; Stata Corporation, College Station, TX).

Results
=======

Study identification and characteristics of enrolled publications
-----------------------------------------------------------------

347 publications were identified after initial screening. After scoring out duplicates by reading the titles and abstracts, 310 publications were removed. Then, 37 full-text publications were assessed for eligibility. Among them, 11 publications were further excluded because relevant studies for one polymorphism were less than three. Finally, 26 publications comprising 39 case-control studies were enrolled for current meta-analysis, and the study selection process was presented in **Figure [1](#F1){ref-type="fig"}**.

The general demographical characteristics of all eligible publications were summarized in **Table [1](#T1){ref-type="table"}**, including *IL18*-rs1946518/ rs187238 [@B30]-[@B37], *IFN-γ*-rs2430561 [@B35], [@B38]-[@B44], *IL12A*-rs568408 [@B45]-[@B47], *IL12B*-rs3212227 [@B42], [@B43], [@B45]-[@B49] and *STAT4*-rs7574865 [@B25], [@B26], [@B50]-[@B53]. In addition, the quality of each enrolled study was assessed by Newcastle-Ottawa Scale (NOS), and the outcomes were presented in (**Table [S1](#SM0){ref-type="supplementary-material"}**).

Meta-analysis
-------------

The detail results of current meta-analysis were shown in **Table [2](#T2){ref-type="table"}**. The overall results suggested that *STAT4-rs7574865* polymorphism conferred a statistically increased risk of HCC in allelic (M vs. W: OR = 1.270, 95%CI = 1.166-1.384, *P*~A~ = 1.760×10^-8^), homozygous (MM vs. WW: OR = 1.651, 95%CI: 1.352-2.016, *P*~A~ = 6.561×10^-7^), recessive (MM vs. MW+WW: OR = 1.330, 95%CI = 1.168-1.516, *P*~A~ = 4.680×10^-7^) and dominant models (MW + MM vs. WW: OR = 1.470, 95%CI = 1.213-1.781, *P*~A~ = 7.092×10^-5^). Moreover, subsection analysis performed on source of control demonstrated that the P-B groups were more susceptible to develop HCC in allelic (M vs. W: OR = 1.320, 95%CI = 1.193-1.461, *P*~A~ = 7.210×10^-8^), homozygous (MM vs. WW: OR = 1.687, 95%CI: 1.326-2.146, *P*~A~ = 1.593×10^-5^), recessive (MM vs. MW+WW: OR = 1.417, 95%CI = 1.242-1.616, *P*~A~ = 1.961×10^-7^) and dominant models (MW + MM vs. WW: OR = 1.447, 95%CI = 1.148-1.824, *P*~A~ = 1.354×10^-3^, **Figure [2](#F2){ref-type="fig"}**), respectively. However, negative results were identified when subgroup analyses were conducted based on HWE, ethnicity and source of control.

Although overall results failed to uncover any positive association between *IL18*-rs1946518/-rs187238, *IFN-γ*-rs2430561, *IL12A*-rs568408 and *IL12B*-rs3212227 polymorphisms and HCC risk, similar to *STAT4-*rs7574865 polymorphism, we identified that *IL18-*rs187238 polymorphism was related to an increased risk of HCC in H-B groups in allelic (M vs. W: OR = 1.604, 95%CI = 1.223-2.103, *P*~A~ = 7.535×10^-4^), heterozygous (MW vs. WW: OR = 1.665, 95%CI: 1.227-2.258, *P*~A~ = 1.058×10^-3^) and dominant models (MW + MM vs. WW: OR = 1.678, 95%CI = 1.246-2.260, *P*~A~ = 6.950×10^-4^). For *IFN-γ-*rs2430561 polymorphism, although overall analysis failed to uncover any positive result, when the subgroup analysis was conducted based on HWE status, we found that for these studies whose control groups conformed to HWE, were significantly associated with an increased risk of HCC in homozygous (MM vs. WW: OR = 2.375, 95%CI = 1.393-4.050, *P*~A~ = 1.450×10^-3^) and recessive models (MM vs. MM+MW: OR = 2.331, 95%CI = 1.471-3.691, *P*~A~ = 2.991×10^-4^), respectively.

Sensitivity Analysis and Publication Bias
-----------------------------------------

Sensitivity analyses were performed to assess the impact of separate case-control study on the data pools (including *IL18*-rs1946518/rs187238, *IFN-γ*-rs2430561, *IL12A*-rs568408, *IL12B*-rs3212227 and *STAT4*-rs7574865 polymorphisms), and the results showed that the pooled ORs and 95%CIs were not been significantly influenced after removing each case-control study in sequence (**Table [S2](#SM0){ref-type="supplementary-material"}** and **Figure [S1](#SM0){ref-type="supplementary-material"}**). Moreover, to evaluate the publication bias, Begg\'s funnel plot and Egger\'s regression test were performed for each genetic polymorphism. By observing the shape of Begg\'s funnel plot, no evidence of publication bias was identified for any polymorphism, which was further verified by Egger\'s regression test (**Table [S3](#SM0){ref-type="supplementary-material"}** and**Figure [S2](#SM0){ref-type="supplementary-material"}**).

Discussion
==========

IL-12 coordinates innate and adaptive immune responses in human beings and is regarded as an important immunomodulatory cytokine in immune system. STAT4 promotes the differentiation of naive CD4^+^ T cells into Th-1 and cytotoxicity of NK cells, as well as the T cell proliferation [@B54], and its activation is mainly triggered by IL-12 signaling. In addition, IL-12 and IL-12R complex could functionally promote the phosphorylation of Jak kinase, promoting cell growth [@B55]. These genes are key genes of IL12 signaling pathway and could functionally work together to exert their function.

It was worth noting that HBV carriers have a greater than 100-fold increased relative risk of developing the HCC [@B56], and evidence has pointed out that IL-12 signaling pathway plays a pivotal role during anti-HBV-infection, and even on HCC tumorigenesis. In addition, evidence also suggested that genetic variations in genes of IL-12 signaling pathway were associated with HCC risk. Nevertheless, till now, no consistent conclusions had been acquired. Therefore, we collected all the available studies and conducted current updated meta-analysis to comprehensively validate the associations between genetic polymorphisms in genes of IL-12 signaling pathway and HCC risk, trying to identify more genetic markers for the screening of HCC.

Here, we identified that *STAT4-rs7574865* polymorphism conferred a statistically increased risk of HCC. As for *IFN-γ-*rs2430561 polymorphism, although overall analysis failed to identify any positive result, we found that for these studies whose control groups conformed to HWE, were significantly associated with an increased risk of HCC. Besides, subgroup analyses based on source of control also identified that the P-B groups were more susceptible to develop HCC in allelic, homozygous, recessive and dominant models for *STAT4-rs7574865* polymorphism, while H-B groups were more susceptible to HCC risk for *IL18-*rs187238 polymorphism in allelic, heterozygous and dominant models, respectively, suggesting that the source of control was also one of the bias influencer.

STAT4 is the key member of STAT protein family, which could transduce signals of cytokine-receptor complexes, and could regulate the transcription of several genes. Through JAK/STAT signaling pathway, IL-12, IL-23 and IFN-1 could induce the response of STAT4, furthermore, the transcription and expression of a variety of genes would be regulated [@B57]-[@B60]. Currently, the influence of *STAT4*-rs7574865 polymorphism on HCC tumorigenesis have been performed on several previous studies, but the results were contraverial[@B25], [@B50], [@B51]. The current analysis revealed that the "M" allele of *STAT4*-rs7574865 polymorphism conferred to an increased risk of HCC. In addition, the pooled results also demonstrated that MM mutant genotype was 1.651 and 1.330-fold increased risk of HCC than WW and MW+WW genotypes, respectively.

IFN-γ plays a critical role in liver function, and it could impact the apoptosis and regeneration of hepatocyte [@B61]. The balance of STAT4 depended IFN-γ expression could affect both the antiviral and antitumor processes [@B62]. In previous study, some incompatible correlations were found between variants in *IFN-γ* gene and the risk of HCC. Saxena *et al.* [@B43] reported that the wild genotype (TT) distribution of *IFN-γ-*rs2430561 polymorphism had the highest frequency for HCC group (27.12 %), and was significantly higher than controls. On the contrast, no statistically significant difference in *IFN-*γ-rs2430561 genotype frequency was presented between chronic hepatitis patients and cirrhotic/HCC group in the study conducted by Bahgat *et al.*[@B38]. In current work, the overall pooled results suggested that there was no statistical connection between rs2430561 polymorphism and HCC risk, while the further subgroup analysis by HWE status found that for these studies whose controls conformed to HWE were significantly associated with an increased risk of HCC, suggesting that HWE status influenced the overall results, causing potential bias.

In this meta-analysis, publication retrieval was carefully done according to the pre-set strict inclusion standards. The advantages of current work should not be buried. Firstly, this is the first study concerned the relationships between all the available genetic polymorphisms in genes of IL-12 signaling pathway and HCC risk. Secondly, we used NOS form to evaluate the quality of each registered study, and low quality studies will be eliminated to further raise the credibility of pooled results. Thirdly, stratification analyses were performed based on ethnicity, source of controls and ethnicity, to decrease the impact of heterogeneity sources, thus we could obtain more accurate results. Fourthly, recognized formula was used to adjust the results, avoiding false positive results. Fifthly, sensitivity analysis was conducted to confirm the stability of current conclusions, and Egger\'s test and Begg\'s funnel plot were carried out to detect potential publication bias. On the contrast, several disadvantages should also be listed here. In the first place, there were no sufficient samples for several genetic polymorphisms, which might provide an untrustworthy result. What\'s more, we only enrolled publications written in English or Chinese, missing publications from other languages may cause potential bias. Last but not the least, we failed to obtain the detail histological subtypes of HCC patients, therefore, stratification analysis based on histological type cannot be conducted.

To conclude, the present meta-analysis suggests that the *STAT4*-rs7574865 polymorphism is a risk factor for HCC patients.
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Study selection process for each gene enrolled.
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###### 

Characteristics of eligible enrolled studies.

  Gene      Polymorphism   First author              Year   Ethnicity   Source of Control   Cancer Type   Case   Control                      
  --------- -------------- ------------------------- ------ ----------- ------------------- ------------- ------ --------- ----- ----- ------ ------
  *IL18*    rs1946518      Teixeira *et al.[@B35]*   2013   mixed       P-B                 HCC           38     56        18    85    105    12
            rs1946518      Lau *et al.^27^*          2016   Asian       H-B                 HCC           88     167       87    148   276    135
            rs1946518      Bao *et al.^25^*          2015   Asian       P-B                 HCC           37     73        43    41    76     48
            rs1946518      Migita *et al.^29^*       2009   Asian       P-B                 HCC           13     26        8     20    30     13
            rs1946518      Chen *et al.^26^*         2012   Asian       P-B                 HCC           47     126       55    83    156    61
            rs1946518      Karra *et al.^28^*        2015   African     P-B                 HCC           70     152       49    102   144    34
            rs1946518      Zhang *et al.^32^*        2016   Asian       P-B                 HCC           32     55        22    23    66     38
            rs187238       Kim *et al.^31^*          2009   Asian       H-B                 HCC           37     17        2     434   122    2
            rs187238       Teixeira *et al.[@B35]*   2013   mixed       P-B                 HCC           57     48        7     100   84     18
            rs187238       Lau *et al.^27^*          2016   Asian       H-B                 HCC           266    73        3     476   78     5
            rs187238       Bao *et al.^25^*          2015   Asian       P-B                 HCC           122    28        3     106   54     5
            rs187238       Migita *et al.^29^*       2009   Asian       P-B                 HCC           43     3         1     52    10     1
            rs187238       Chen *et al.^26^*         2012   Asian       P-B                 HCC           159    59        10    173   115    12
            rs187238       Karra *et al.^28^*        2015   African     P-B                 HCC           123    134       14    159   108    13
            rs187238       Zhang *et al.^32^*        2016   Asian       P-B                 HCC           82     25        2     99    24     4
  *IFN-γ*   rs2430561      Teixeira *et al.^30^*     2013   Caucasian   P-B                 HCC           40     50        21    79    82     41
            rs2430561      Kim *et al.^35^*          2013   Asian       H-B                 HCC           133    31        6     131   38     2
            rs2430561      Migita *et al.^36^*       2005   Asian       H-B                 HCC           41     7         0     157   31     0
            rs2430561      Ben-Ari *et al.^39^*      2003   Caucasian   P-B                 HCC           3      7         0     18    24     6
            rs2430561      Nieters *et al.^37^*      2005   Asian       H-B                 HCC           155    94        164   86           
            rs2430561      Saxena *et al.^38^*       2014   Asian       P-B                 HCC           15     28        16    52    77     17
            rs2430561      Bouzgarrou *et al.^34^*   2009   African     P-B                 HCC           17     21        20    33    47     23
            rs2430561      Bahgat *et al.^33^*       2015   Egyptian    P-B                 HCC           10     24        16    6     15     4
  *IL12A*   rs568408       Elsayed *et al.^40^*      2016   Egyptian    P-B                 HCC           42     26        10    84    7      1
            rs568408       Tan *et al.^42^*          2015   Asian       P-B                 HCC           313    76        6     511   161    14
            rs568408       Liu *et al.^41^*          2011   Asian       P-B                 HCC           504    277       21    631   220    10
  *IL12B*   rs3212227      Saxena *et al.^38^*       2014   Asian       P-B                 HCC           19     31        9     63    71     14
            rs3212227      Elsayed *et al.^40^*      2016   Egyptian    P-B                 HCC           41     22        15    38    40     14
            rs3212227      Nieters *et al.^37^*      2005   Asian       H-B                 HCC           56     193       72    178          
            rs3212227      Tan *et al.^42^*          2015   Asian       P-B                 HCC           104    201       90    200   347    139
            rs3212227      Ognjanovic *et al.^43^*   2009   mixed       P-B                 HCC           57     60        128   95           
            rs3212227      Liu *et al.^41^*          2011   Asian       P-B                 HCC           249    422       160   272   414    158
            rs3212227      Yang *et al.^44^*         2011   Asian       H-B                 HCC           156    309       143   195   302    115
  *STAT4*   rs7574865      Chanthra *et al.^45^*     2015   Asian       P-B                 HCC           19     86        87    28    100    62
            rs7574865      Chen *et al.^21^*         2013   Asian       H-B                 HCC           35     217       249   75    327    370
            rs7574865      Chen *et al.^46^*         2015   Asian       P-B                 HCC           40     211       257   343   1333   1298
            rs7574865      Clark *et al.^20^*        2013   Asian       H-B                 HCC           20     102       117   28    92     86
            rs7574865      Kim *et al.^47^*          2015   Asian       P-B                 HCC           20     103       160   306   1251   1293
            rs7574865      Liao *et al.^48^*         2014   Asian       P-B                 HCC           25     93        104   27    113    97

P-B: population-based; H-B: hospital-based; HCC: Hepatocellular Carcinoma; W: wild allele; M: mutant allele.

###### 

Results of meta-analysis.

  Gene      Polymorphism   Comparison     Subgroup    N   *P*~H~   *P*~A~             Random                 Fixed
  --------- -------------- -------------- ----------- --- -------- ------------------ ---------------------- ---------------------
  *IL18*    rs187238       M vs. W        Overall     8   0.000    9.976×10^-1^       1.000 (0.736-1.359)    1.033 (0.904-1.181)
            rs187238       M vs. W        Asian       6   0.000    8.103×10^-1^       0.948 (0.615-1.462)    0.951 (0.801-1.130)
            rs187238       M vs. W        H-B         2   0.577    **7.535×10^-4^**   1.604 (1.223-2.103)    1.597 (1.216-2.096)
            rs187238       M vs. W        P-B         6   0.002    3.018×10^-1^       0.841 (0.605-1.168)    0.906 (0.777-1.056)
            rs187238       M vs. W        Y           7   0.000    6.355×10^-1^       0.926 (0.674-1.272)    0.997 (0.868-1.145)
            rs187238       WM vs. WW      Overall     8   0.000    9.445×10^-1^       0.986 (0.657-1.480)    1.054 (0.897-1.240)
            rs187238       WM vs. WW      Asian       6   0.000    6.487×10^-1^       0.881 (0.509-1.522)    0.924 (0.757-1.129)
            rs187238       WM vs. WW      H-B         2   0.946    **1.058×10^-3^**   1.665 (1.227-2.258)    1.665 (1.227-2.259)
            rs187238       WM vs. WW      P-B         6   0.000    4.054×10^-1^       0.814 (0.501-1.322)    0.887 (0.733-1.074)
            rs187238       WM vs. WW      Y           7   0.000    7.038×10^-1^       0.917 (0.588-1.432)    1.023 (0.865-1.209)
            rs187238       WM+MM vs. WW   Overall     8   0.000    9.645×10^-1^       0.991 (0.671-1.463)    1.050 (0.897-1.228)
            rs187238       WM+MM vs. WW   Asian       6   0.000    7.008×10^-1^       0.903 (0.535-1.522)    0.933 (0.769-1.132)
            rs187238       WM+MM vs. WW   H-B         2   0.790    **6.950×10^-4^**   1.678 (1.246-2.260)    1.676 (1.243-2.258)
            rs187238       WM+MM vs. WW   P-B         6   0.000    3.724×10^-1^       0.815 (0.519-1.278)    0.883 (0.735-1.062)
            rs187238       WM+MM vs. WW   Y           7   0.000    6.719×10^-1^       0.913 (0.601-1.389)    1.011 (0.860-1.189)
            rs187238       MM vs. WW      Overall     8   0.298    9.495×10^-1^       1.034 (0.641-1.667)    0.987 (0.654-1.488)
            rs187238       MM vs. WW      Asian       6   0.212    8.754×10^-1^       1.086 (0.516-2.283)    0.955 (0.540-1.691)
            rs187238       MM vs. WW      H-B         2   0.051    3.368×10^-1^       3.216 (0.296-34.892)   1.934 (0.618-6.050)
            rs187238       MM vs. WW      P-B         6   0.806    6.383×10^-1^       0.906 (0.58^-1^.416)   0.900 (0.579-1.398)
            rs187238       MM vs. WW      Y           7   0.885    6.731×10^-1^       0.920 (0.600-1.408)    0.913 (0.599-1.392)
            rs187238       MM vs. WM+WW   Overall     8   0.431    9.058×10^-1^       1.012 (0.671-1.526)    0.976 (0.650-1.464)
            rs187238       MM vs. WM+WW   Asian       6   0.299    8.563×10^-1^       1.145 (0.587-2.234)    1.054 (0.598-1.857)
            rs187238       MM vs. WM+WW   H-B         2   0.055    3.757×10^-1^       2.878 (0.278-29.858)   1.777 (0.570-5.542)
            rs187238       MM vs. WM+WW   P-B         6   0.921    6.329×10^-1^       0.906 (0.584-1.405)    0.900 (0.583-1.389)
            rs187238       MM vs. WM+WW   Y           7   0.963    6.419×10^-1^       0.912 (0.600-1.388)    0.906 (0.598-1.373)
            rs1946518      W vs. M        Overall     7   0.012    2.739×10^-1^       1.107 (0.923-1.329)    1.125 (1.014-1.249)
            rs1946518      W vs. M        Asian       5   0.083    9.618×10^-1^       0.995 (0.822-1.206)    1.024 (0.905-1.158)
            rs1946518      W vs. M        P-B         6   0.009    3.427×10^-1^       1.117 (0.889-1.404)    1.163 (1.027-1.317)
            rs1946518      W vs. M        Y           6   0.019    5.521×10^-1^       1.060 (0.875-1.285)    1.094 (0.980-1.220)
            rs1946518      WM vs. WW      Overall     7   0.248    7.791×10^-2^       1.162 (0.945-1.430)    1.169 (0.983-1.391)
            rs1946518      WM vs. WW      Asian       5   0.269    5.398×10^-1^       1.063 (0.823-1.373)    1.069 (0.864-1.322)
            rs1946518      WM vs. WW      P-B         6   0.229    4.382×10^-2^       1.206 (0.939-1.549)    1.235 (1.006-1.517)
            rs1946518      WM vs. WW      Y           6   0.164    1.043×10^-1^       1.152 (0.900-1.473)    1.166 (0.969-1.404)
            rs1946518      WM+MM vs. WW   Overall     7   0.057    2.034×10^-1^       1.176 (0.916-1.510)    1.202 (1.019-1.417)
            rs1946518      WM+MM vs. WW   Asian       5   0.112    5.578×10^-1^       1.035 (0.768-1.396)    1.062 (0.869-1.297)
            rs1946518      WM+MM vs. WW   P-B         6   0.051    2.341×10^-1^       1.203 (0.887-1.633)    1.275 (1.048-1.550)
            rs1946518      WM+MM vs. WW   Y           6   0.038    3.901×10^-1^       1.135 (0.850-1.515)    1.176 (0.987-1.401)
            rs1946518      MM vs. WW      Overall     7   0.003    2.675×10^-1^       1.268 (0.833-1.931)    1.269 (1.024-1.573)
            rs1946518      MM vs. WW      Asian       5   0.075    9.398×10^-1^       0.985 (0.663-1.463)    1.043 (0.815-1.335)
            rs1946518      MM vs. WW      P-B         6   0.002    3.262×10^-1^       1.307 (0.766-2.231)    1.369 (1.054-1.777)
            rs1946518      MM vs. WW      Y           6   0.016    5.732×10^-1^       1.123 (0.751-1.679)    1.182 (0.946-1.477)
            rs1946518      MM vs. WM+WW   Overall     7   0.029    3.453×10^-1^       1.155 (0.856-1.559)    1.141 (0.953-1.366)
            rs1946518      MM vs. WM+WW   Asian       5   0.350    9.856×10^-1^       0.996 (0.799-1.240)    1.002 (0.818-1.227)
            rs1946518      MM vs. WM+WW   P-B         6   0.017    4.088×10^-1^       1.179 (0.797-1.744)    1.178 (0.945-1.469)
            rs1946518      MM vs. WM+WW   Y           6   0.183    4.279×10^-1^       1.062 (0.833-1.353)    1.078 (0.895-1.298)
  *IFN-γ*   rs2430561      W vs. M        Overall     5   0.392    3.251×10^-2^       1.239 (1.016-1.511)    1.237 (1.018-1.503)
            rs2430561      W vs. M        Asian       2   0.126    6.921×10^-2^       1.328 (0.822-2.145)    1.336 (0.977-1.825)
            rs2430561      W vs. M        Caucasian   2   0.344    4.878×10^-1^       1.111 (0.824-1.499)    1.111 (0.825-1.498)
            rs2430561      W vs. M        P-B         4   0.338    2.146×10^-2^       1.300 (1.030-1.641)    1.288 (1.038-1.598)
            rs2430561      W vs. M        Y           4   0.489    1.284×10^-2^       1.359 (1.068-1.730)    1.358 (1.067-1.728)
            rs2430561      WM vs. WW      Overall     5   0.796    9.487×10^-1^       1.009 (0.752-1.355)    1.010 (0.753-1.354)
            rs2430561      WM vs. WW      Asian       2   0.324    7.893×10^-1^       0.942 (0.614-1.445)    0.944 (0.617-1.443)
            rs2430561      WM vs. WW      Caucasian   2   0.734    5.353×10^-1^       1.162 (0.722-1.870)    1.162 (0.723-1.869)
            rs2430561      WM vs. WW      P-B         4   0.884    5.403×10^-1^       1.116 (0.784-1.589)    1.117 (0.785-1.589)
            rs2430561      WM vs. WW      Y           4   0.799    6.838×10^-1^       0.928 (0.648-1.327)    0.929 (0.650-1.326)
            rs2430561      WM+MM vs. WW   Overall     8   0.943    2.454×10^-1^       1.131 (0.916-1.397)    1.133 (0.918-1.398)
            rs2430561      WM+MM vs. WW   Asian       4   0.544    4.033×10^-1^       1.114 (0.859-1.445)    1.116 (0.862-1.445)
            rs2430561      WM+MM vs. WW   Caucasian   3   0.959    4.531×10^-1^       1.176 (0.770-1.797)    1.176 (0.770-1.797)
            rs2430561      WM+MM vs. WW   H-B         3   0.688    7.673×10^-1^       1.044 (0.788-1.383)    1.043 (0.788-1.381)
            rs2430561      WM+MM vs. WW   P-B         5   0.938    1.585×10^-1^       1.255 (0.911-1.727)    1.258 (0.914-1.730)
            rs2430561      WM+MM vs. WW   Y           5   0.755    3.910×10^-1^       1.148 (0.828-1.594)    1.153 (0.833-1.596)
            rs2430561      WM+MM vs. WW   Overall     5   0.768    3.459×10^-1^       1.138 (0.864-1.498)    1.141 (0.867-1.500)
            rs2430561      WM+MM vs. WW   Asian       2   0.181    5.545×10^-1^       1.162 (0.665-2.032)    1.129 (0.755-1.687)
            rs2430561      WM+MM vs. WW   Caucasian   2   0.872    5.184×10^-1^       1.157 (0.744-1.802)    1.157 (0.743-1.802)
            rs2430561      WM+MM vs. WW   P-B         4   0.853    1.790×10^-1^       1.248 (0.899-1.731)    1.251 (0.902-1.734)
            rs2430561      WM+MM vs. WW   Y           4   0.610    4.380×10^-1^       1.137 (0.812-1.591)    1.141 (0.817-1.593)
            rs2430561      MM vs. WW      Overall     5   0.271    1.164×10^-2^       1.777 (1.088-2.903)    1.683 (1.123-2.523)
            rs2430561      MM vs. WW      Asian       2   0.916    3.909×10^-3^       3.188 (1.460-6.964)    3.177 (1.449-6.968)
            rs2430561      MM vs. WW      Caucasian   2   0.298    6.153×10^-1^       1.187 (0.615-2.293)    1.163 (0.645-2.098)
            rs2430561      MM vs. WW      P-B         4   0.198    2.618×10^-2^       1.725 (0.989-3.011)    1.610 (1.058-2.449)
            rs2430561      MM vs. WW      Y           4   0.754    **1.450×10^-3^**   2.375 (1.393-4.050)    2.372 (1.394-4.035)
            rs2430561      MM vs. WM+WW   Overall     5   0.144    7.219×10^-3^       1.785 (1.075-2.966)    1.624 (1.140-2.313)
            rs2430561      MM vs. WM+WW   Asian       2   0.920    2.773×10^-3^       2.871 (1.438-5.731)    2.880 (1.440-5.760)
            rs2430561      MM vs. WM+WW   Caucasian   2   0.151    6.576×10^-1^       1.294 (0.512-3.269)    1.123 (0.671-1.880)
            rs2430561      MM vs. WM+WW   P-B         4   0.102    1.646×10^-2^       1.713 (0.979-2.997)    1.562 (1.085-2.248)
            rs2430561      MM vs. WM+WW   Y           4   0.847    **2.991×10^-4^**   2.331 (1.471-3.691)    2.333 (1.474-3.693)
  *STAT4*   rs7574865      W vs. M        Overall     6   0.395    **1.760×10^-8^**   1.270 (1.166-1.384)    1.272 (1.170-1.382)
            rs7574865      W vs. M        H-B         2   0.300    3.909×10^-2^       1.172 (1.003-1.370)    1.169 (1.008-1.356)
            rs7574865      W vs. M        P-B         4   0.503    **7.210×10^-8^**   1.320 (1.193-1.461)    1.321 (1.194-1.462)
            rs7574865      WM vs. WW      Overall     6   0.845    9.838×10^-3^       1.302 (1.064-1.592)    1.303 (1.066-1.593)
            rs7574865      WM vs. WW      H-B         2   0.824    3.922×10^-2^       1.462 (1.020-2.097)    1.461 (1.019-2.096)
            rs7574865      WM vs. WW      P-B         4   0.706    8.236×10^-2^       1.234 (0.968-1.574)    1.239 (0.973-1.577)
            rs7574865      WM+MM vs. WW   Overall     6   0.841    **7.092×10^-5^**   1.470 (1.213-1.781)    1.474 (1.217-1.785)
            rs7574865      WM+MM vs. WW   H-B         2   0.624    1.768×10^-2^       1.520 (1.077-2.145)    1.518 (1.075-2.143)
            rs7574865      WM+MM vs. WW   P-B         4   0.623    **1.354×10^-3^**   1.447 (1.148-1.824)    1.456 (1.157-1.833)
            rs7574865      MM vs. WW      Overall     6   0.755    **6.561×10^-7^**   1.651 (1.352-2.016)    1.658 (1.359-2.024)
            rs7574865      MM vs. WW      H-B         2   0.479    1.355×10^-2^       1.574 (1.101-2.251)    1.571 (1.098-2.248)
            rs7574865      MM vs. WW      P-B         4   0.564    **1.593×10^-5^**   1.687 (1.326-2.146)    1.696 (1.334-2.156)
            rs7574865      MM vs. WM+WW   Overall     6   0.249    **4.680×10^-7^**   1.330 (1.168-1.516)    1.322 (1.186-1.473)
            rs7574865      MM vs. WM+WW   H-B         2   0.324    1.889×10^-1^       1.138 (0.938-1.380)    1.138 (0.938-1.380)
            rs7574865      MM vs. WM+WW   P-B         4   0.518    **1.961×10^-7^**   1.417 (1.242-1.616)    1.417 (1.243-1.617)
  *IL12A*   rs568408       W vs. M        Overall     3   0.000    1.096×10^-1^       1.926 (0.863-4.299)    1.363 (1.180-1.574)
            rs568408       W vs. M        Asian       2   0.000    7.654×10^-1^       1.105 (0.573-2.130)    1.235 (1.064-1.434)
            rs568408       WM vs. WW      Overall     3   0.000    1.450×10^-1^       1.804 (0.816-3.988)    1.342 (1.135-1.587)
            rs568408       WM vs. WW      Asian       2   0.000    7.665×10^-1^       1.112 (0.552-2.242)    1.245 (1.048-1.479)
            rs568408       WM+MM vs. WW   Overall     3   0.000    1.193×10^-1^       1.982 (0.838-4.689)    1.386 (1.178-1.631)
            rs568408       WM+MM vs. WW   Asian       2   0.000    7.580×10^-1^       1.123 (0.538-2.345)    1.261 (1.066-1.492)
            rs568408       WM+MM vs. WW   Overall     3   0.000    1.193×10^-1^       1.982 (0.838-4.689)    1.386 (1.178-1.631)
            rs568408       WM+MM vs. WW   Asian       2   0.000    7.580×10^-1^       1.123 (0.538-2.345)    1.261 (1.066-1.492)
            rs568408       MM vs. WW      Overall     3   0.007    2.029×10^-1^       2.574 (0.601-11.033)   2.151 (1.285-3.603)
            rs568408       MM vs. WW      Asian       2   0.035    6.075×10^-1^       1.404 (0.384-5.130)    1.576 (0.897-2.771)
            rs568408       MM vs. WM+WW   Overall     3   0.025    2.298×10^-1^       2.158 (0.615-7.568)    1.957 (1.160-3.300)
            rs568408       MM vs. WM+WW   Asian       2   0.072    5.886×10^-1^       1.356 (0.450-4.085)    1.487 (0.843-2.622)
  *IL12B*   rs3212227      W vs. M        Overall     5   0.301    6.458×10^-3^       1.129 (1.021-1.247)    1.127 (1.034-1.228)
            rs3212227      W vs. M        Asian       4   0.344    3.593×10^-3^       1.141 (1.039-1.254)    1.139 (1.043-1.243)
            rs3212227      W vs. M        P-B         4   0.439    1.334×10^-1^       1.081 (0.977-1.197)    1.081 (0.976-1.197)
            rs3212227      WM vs. WW      Overall     5   0.156    7.995×10^-2^       1.115 (0.914-1.360)    1.133 (0.985-1.302)
            rs3212227      WM vs. WW      Asian       4   0.769    2.749×10^-2^       1.174 (1.018-1.354)    1.174 (1.018-1.354)
            rs3212227      WM vs. WW      P-B         4   0.138    3.564×10^-1^       1.048 (0.805-1.365)    1.080 (0.917-1.273)
            rs3212227      WM+MM vs. WW   Overall     7   0.282    2.390×10^-3^       1.210 (1.049-1.394)    1.205 (1.068-1.360)
            rs3212227      WM+MM vs. WW   Asian       5   0.624    1.947×10^-3^       1.224 (1.077-1.391)    1.224 (1.077-1.391)
            rs3212227      WM+MM vs. WW   H-B         2   0.906    3.978×10^-3^       1.366 (1.105-1.688)    1.366 (1.105-1.688)
            rs3212227      WM+MM vs. WW   P-B         5   0.243    8.896×10^-2^       1.139 (0.941-1.378)    1.136 (0.981-1.315)
            rs3212227      WM+MM vs. WW   Overall     5   0.181    1.900×10^-2^       1.162 (0.970-1.392)    1.170 (1.026-1.335)
            rs3212227      WM+MM vs. WW   Asian       4   0.537    6.362×10^-3^       1.206 (1.054-1.381)    1.207 (1.054-1.381)
            rs3212227      WM+MM vs. WW   P-B         4   0.221    2.023×10^-1^       1.096 (0.884-1.358)    1.106 (0.947-1.291)
            rs3212227      MM vs. WW      Overall     5   0.429    6.126×10^-3^       1.278 (1.073-1.522)    1.277 (1.072-1.520)
            rs3212227      MM vs. WW      Asian       4   0.323    5.045×10^-3^       1.301 (1.067-1.586)    1.291 (1.080-1.543)
            rs3212227      MM vs. WW      P-B         4   0.605    1.250×10^-1^       1.179 (0.957-1.451)    1.177 (0.956-1.448)
            rs3212227      MM vs. WM+WW   Overall     5   0.629    3.630×10^-2^       1.176 (1.011-1.367)    1.175 (1.010-1.367)
            rs3212227      MM vs. WM+WW   Asian       4   0.476    4.563×10^-2^       1.170 (1.004-1.365)    1.170 (1.003-1.364)
            rs3212227      MM vs. WM+WW   P-B         4   0.681    2.405×10^-1^       1.116 (0.931-1.336)    1.114 (0.930-1.335)

P-B: population-based; H-B: hospital-based; W: wild allele; M: mutant allele; HWE: Hardy-Weinberg equilibrium (Y: conform to HWE; N: not conform to HWE). Characters with bold mean statistically significant.
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